Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

307
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
307
Inflammation01:38

Inflammation

53.6K
Overview
53.6K
Allergic Reactions02:06

Allergic Reactions

27.5K
Overview
27.5K
Hypersensitivities01:30

Hypersensitivities

684
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
684
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Cross-reactivity00:42

Cross-reactivity

31.2K
Overview
31.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarker affliction classes contribute additively to observed dementia severity and prospective conversion risk.

Journal of Alzheimer's disease : JAD·2026
Same author

Progress in mast cell activation syndrome: the global consensus-2 diagnostic criteria at six years.

Diagnosis (Berlin, Germany)·2026
Same author

Chemical Intolerance Is Associated with Autism Spectrum and Attention Deficit Disorders: A Five-Country Cross-National Replication Analysis.

Journal of xenobiotics·2026
Same author

Affliction class moderates the impact of neurodegeneration: Implications for A/T/N.

Journal of Alzheimer's disease : JAD·2025
Same author

Affliction class moderates the dementing impact of amyloidopathy.

Neuropsychology·2025
Same author

Effects of the COVID-19 pandemic on individuals with chemical intolerance.

Family medicine and community health·2025

Related Experiment Video

Updated: Jul 10, 2025

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

10.4K

Chemical Intolerance and Mast Cell Activation: A Suspicious Synchronicity.

Raymond F Palmer1, Tania T Dempsey2, Lawrence B Afrin2

  • 1Department of Family and Community Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA.

Journal of Xenobiotics
|November 21, 2023
PubMed
Summary

Chemical Intolerance (CI) is linked to Mast Cell Activation Syndrome (MCAS). This study confirms that most MCAS patients experience CI, suggesting a shared underlying biological mechanism for their multisystem symptoms.

Keywords:
chemical intolerancemast cell activation syndrome (MCAS)toxicant-induced loss of tolerance

More Related Videos

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
08:25

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Published on: April 27, 2021

2.4K
Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
16:01

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis

Published on: January 26, 2015

13.2K

Related Experiment Videos

Last Updated: Jul 10, 2025

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

10.4K
An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
08:25

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Published on: April 27, 2021

2.4K
Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
16:01

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis

Published on: January 26, 2015

13.2K

Area of Science:

  • Environmental Health
  • Immunology
  • Toxicology

Background:

  • Chemical Intolerance (CI) involves multi-system symptoms triggered by various exposures.
  • The underlying biological mechanism of CI remains largely unknown.
  • Previous research suggests a link between CI and Mast Cell Activation Syndrome (MCAS).

Purpose of the Study:

  • To confirm the high prevalence of CI in MCAS patients.
  • To investigate symptom and intolerance parallels between CI and MCAS.
  • To explore a potential shared disease mechanism.

Main Methods:

  • Five hundred forty-four MCAS patients were assessed.
  • A validated assessment instrument was used to assign clinical MCAS scores.
  • The Quick Environmental Exposure Sensitivity Index was used to assess CI.

Main Results:

  • The study confirmed that a majority of MCAS patients also report CI.
  • A significant overlap was observed between CI symptoms and various ICD-10 diagnostic categories.
  • Findings support the hypothesis of a shared underlying mechanism between MCAS and CI.

Conclusions:

  • CI initiators include pesticides, volatile organic compounds, combustion products, and mold.
  • This study identifies a potential new biological mechanism for CI.
  • This mechanism may explain medically unexplained symptoms triggered by xenobiotics.